Bone Graft and Substitutes Market

Bone Graft and Substitutes Market - Trends,
Analysis and Forecast to 2025
A bone graft repairs and rebuilds diseased bone and transplants bone tissues of the hips, knees, spine,
and various other bones in the body. Moreover, it repairs bone loss caused by fractures and cancers.
The body accepts the newly implanted graft and provides a framework for growth of new living bone.
Bone grafts can be obtained either from the patient’s own body, a donor or can be entirely man-made
from natural or synthetic materials. Autografts and allograft are the most common types of bone grafts.
In Allograft, bone is obtained from a deceased donor or a cadaver that is sterilized and stored in the
tissue or bone banks. In autografts, bone is obtained from the patient’s own body parts such as ribs,
pelvis, wrist, and hips. Furthermore, bone graft substitutes made up of materials such as ceramics and
polymers are gaining preference. This is owing to osteoconductive and osteogenerative properties and
easy availability of these grafts.
Request Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/requestsample/1050
Rise in trauma cases are responsible for accelerating growth of the global bone grafts and substitutes
market:
Bone grafting is majorly performed in cases of sinus lift, ridge augmentation, fracture repair, nerve
repositioning, and dental implantation. Bone damage is majorly attributed to rising incidence of trauma
and accident cases across the globe. According to the Centers for Disease Control and Prevention (CDC),
around 2.5 million people were hospitalized in the U.S. in 2014, due to accident injuries, indicating
high risk of bone damage. This in turn, increases the demand for bone grafts and substitutes. The
potential ability of bone grafting to repair the damage using natural mechanism can thus, be helpful and
incorporated for bone healing procedures. Moreover, the National Trauma Institute in 2014, revealed
that economic burden due to trauma cases increased to US$ 671 billion, including healthcare costs and
lost productivity costs. Among geographical regions, North America contributes the maximum share in
the bone grafts and substitutes market, owing to the increasing research and development activities in
the field of bone grafting, which results in development of innovative bone grafts in the region. For
instance, Artoss, Inc., a U.S.- based company introduced a complete line of bone grafts in 2017, which
incorporates use of nanotechnology in the production of these grafts. Various other factors such as
presence of key operating players and collaborative partnerships among the players are responsible for
positioning North America as the largest market for bone grafts and substitutes. On the other hand, Asia
Pacific is expected to gain significant traction, owing to the rise in medical tourism as well as
development of novel bone graft substitutes by regional players, exhibiting equivalent efficiency at
affordable prices.
The global bone grafts and substitutes market was valued at US$ 2,640.1 million in 2016 and is
expected to witness a robust CAGR of 5.5% over the forecast period (2017 - 2025).
Report includes chapters which deeply display the following deliverable about industry :
• Bone Graft and Substitutes Market Research Objective and Assumption
• Bone Graft and Substitutes Market Purview - Report Description, Executive Summary, and
Coherent Opportunity Map (COM)
• Bone Graft and Substitutes Market Dynamics, Regulations, and Trends Analysis - Market
Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Bone Graft and Substitutes Market, By Regions
• Bone Graft and Substitutes Market Competition by Manufacturers including Production, Share,
Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Bone Graft and Substitutes Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Bone Graft and Substitutes Market Manufacturing Cost Analysis including Key Raw Materials
and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Bone Graft and Substitutes Market Forecast including Production, Consumption, Import and
Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Market Dynamics:
Bone grafts and substitutes market witnessed new product launches, partnerships and agreements in last
few months. In October, 2017, DSM Biomedical signed a partnership agreement with a privately held
orthobiologics company, Cerapedics to develop peptide enhanced bone graft. The strategic partnership
will complement DSM’s material regeneration abilities with Cerapedics synthetic small peptide (P-15)
technology. In April, 2017, BoneSupport AB extended its U.S distribution agreement with Zimmer Biomet
for its Cerament bone void filler product. According to the agreement Zimmer will have exclusive rights
to distribute portfolio of bone void fillers for trauma, orthopedics and foot and ankle applications. In
May, 2017, NovaBone introduced NovaBone IRM and IRM MacroPOR to its product portfolio. According
to NovaBone, the products possess osteogenic and osteoblastic characteristics and are highly irrigation
resistant. Increase in awareness of non-invasive technologies among the patients and shift towards
derived forms of bone graft substitutes are also expected to favor the market in near future.
Browse Complete Report For More Information @ https://www.coherentmarketinsights.com/marketinsight/bone-graft-and-substitutes-market-1050
Consistent development resulting in innovative bone grafting products expected to propel growth of the
market:
A large number of players are focused on the development of novel products for bone grafting. For
instance, in May 2017, the National Chemical Laboratory in India, developed two novel bone graft
substitutes that are aimed towards augmenting and regenerating the bones that are lost during accident
or injuries. The products are now in clinical trial phase for performance testing and are expected to be
available in prices lesser than the currently available imported varieties of the same, leading to
emergence of local players in the Asia Pacific market. Moreover, companies are also entering into
mergers and acquisitions to strengthen their position in the market. For instance, Kuros Biosciences
acquired Xpand Biotechnology in 2016, wherein Kuros will use Xpand’s granular formulation for the
production of novel bone graft substitutes. Major players operating the global bone graft and substitutes
market include Ace Surgical Supply Co., Inc., NovaBone Product LLC, Medtronic Plc, Stryker
Corporation, Zimmer Biomet Holdings, Inc., BioHorizons Implant Systems, Inc., Novadip Biosciences,
Orthofix International N.V., Globus Medical, Inc., and Bone Therapeutics SA.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

A bone graft repairs and rebuilds diseased bone and transplants bone tissues of the hips, knees, spine, and various other bones in the body.

Download Report